RFL
NYSE · Pharmaceuticals
Rafael Holdings Inc-Class B
$2.05
+0.03 (+1.49%)
Open$2.05
Previous Close$2.02
Day High$2.14
Day Low$2.02
52W High$3.96
52W Low$1.12
Volume—
Avg Volume90.6K
Market Cap108.70M
P/E Ratio—
EPS$-0.68
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.65M | 1.26M | 15.20M |
| Net Income | -55,029,847 | -37,870,364 | 4.84M |
| Profit Margin | -3,328.2% | -3,161.8% | 31.9% |
| EBITDA | -52,059,333 | -37,816,459 | 7.34M |
| Free Cash Flow | — | — | 4.44M |
| Rev Growth | +30.8% | +30.8% | +5.7% |
| Debt/Equity | 0.01 | 0.01 | 0.33 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |